Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Biomed Mater Res B Appl Biomater ; 110(4): 806-816, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-34716750

RESUMO

Plasma spray nano-hydroxyapatite-coated titanium intramedullary implants doped either with 5% zinc, 2.5% strontium, and 2.5% fluorine ions or with 5% zinc, 5% strontium, and 2.5% silver ions were evaluated compared with plasma spray nano-hydroxyapatite-coated titanium intramedullary implant and uncoated titanium intramedullary implants for open reduction and internal immobilization in 24 clinical cases of long bone fracture repair in dogs. Fracture-healing limb outcome was evaluated clinically, that is, radiographically. Biochemical estimation of serum calcium, serum phosphorus, alkaline phosphatase (ALP), and bone markers (bone ALP [BALP] and C-telopeptide of type 1 collagen [CTX]) was carried out on 0th day, 3rd week, 6th, and 9th week postoperatively. Multi-ion-doped plasma spray nano-hydroxyapatite-coated titanium intramedullary implants were found to be superior to plasma spray nano-hydroxyapatite-coated titanium intramedullary implants and uncoated titanium intramedullary implants in terms of all the parameters studied. Using plasma spray nano-hydroxyapatite-coated titanium implants doped with multi ions, that is, 5% zinc, 5% strontium, and 2.5% silver gave the best results in fracture repair followed by the implants doped with 5% zinc, 2.5% strontium, and 2.5% fluorine ions. Earliest and excellent limb usage with no postoperative complications was the hallmark of the use of these multi-ion-doped implants with higher serum calcium, serum phosphorus, ALP, BALP, and CTX values up to 3rd postoperative week and no lameness on the 21st day.


Assuntos
Durapatita , Fraturas Ósseas , Animais , Pinos Ortopédicos , Materiais Revestidos Biocompatíveis/farmacologia , Cães , Durapatita/farmacologia , Íons , Osseointegração , Propriedades de Superfície , Titânio
2.
Res Vet Sci ; 133: 48-52, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32932198

RESUMO

Bovine ocular squamous cell carcinoma (BOSCC) also called cancer eye, represents the most economically important neoplasm in large animals. Hereditary factors, environmental factors, lack of eyelid pigmentation, age and dietary habits have all been reported to play a role in the etiopathogenesis of bovine ocular squamous cell carcinoma. In group I, six animals with small, localized eye cancer where vision was not affected were included and subjected to intralesional injection of Bacillus Calmette- Guerin (BCG) vaccine at 0, 14, 35, and 56 days interval. In group II (six animals), surgical excision and Mitomycin C 0.04% topically on alternate weeks for two months as adjunctive therapy. All the animals recovered completely with no recurrence for a follow up period of one year.


Assuntos
Antibióticos Antineoplásicos/uso terapêutico , Vacina BCG/normas , Carcinoma de Células Escamosas/veterinária , Doenças dos Bovinos/tratamento farmacológico , Neoplasias Oculares/veterinária , Mitomicina/uso terapêutico , Administração Intravesical , Animais , Antibióticos Antineoplásicos/administração & dosagem , Antibióticos Antineoplásicos/normas , Vacina BCG/administração & dosagem , Vacina BCG/uso terapêutico , Carcinoma de Células Escamosas/tratamento farmacológico , Bovinos , Terapia Combinada/veterinária , Neoplasias Oculares/tratamento farmacológico , Feminino , Humanos , Masculino , Mitomicina/administração & dosagem , Mitomicina/normas , Inibidores da Síntese de Ácido Nucleico/administração & dosagem , Inibidores da Síntese de Ácido Nucleico/normas , Inibidores da Síntese de Ácido Nucleico/uso terapêutico , Estudos Prospectivos , Neoplasias da Bexiga Urinária/tratamento farmacológico , Neoplasias da Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/veterinária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA